Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

252 ARTÍCULOS , VIENDO DEL 196 AL 210

The diagnostic value of clinical neurophysiology in hyperkinetic movement disorders: A systematic review

van der Veen S, Klamer MR, Elting JWJ, Koelman JHTM, van der Stouwe AMM, Tijssen MAJ.

Parkinsonism Relat Disord. 2021 Aug;89:176-185. doi: 10.1016/j.parkreldis.2021.07.033. Epub 2021 Jul 31.

Juvenile Huntington's disease masquerading as progressive myoclonus epilepsy

Thakor B, Jagtap SA, Joshi A.

Epilepsy Behav Rep. 2021 Jul 15;16:100470. doi: 10.1016/j.ebr.2021.100470. eCollection 2021.

New-Onset Movement Disorders in COVID-19: Much Ado about Nothing?

Nirenberg MJ.

Tremor Other Hyperkinet Mov (N Y). 2021 Jul 28;11:31. doi: 10.5334/tohm.644. eCollection 2021.

A novel biallelic LMNB2 variant in a patient with progressive myoclonus epilepsy and ataxia: A case of laminopathy

Farajzadeh Valilou S, Karimzad Hagh J, Salimi Asl M, Abdi Rad I, Edizadeh M, Pooladi A.

Clin Case Rep. 2021 Aug 23;9(8):e04520. doi: 10.1002/ccr3.4520. eCollection 2021 Aug.

Atypical Presentation of Enterovirus D68 Infection as Opsoclonus-Myoclonus Syndrome

Martin MJ, Rose SC.

Pediatr Neurol. 2021 Nov;124:24-25. doi: 10.1016/j.pediatrneurol.2021.07.005. Epub 2021 Aug 4.

Gastrointestinal disorders in hyperkinetic movement disorders and ataxia

Pradeep S, Mehanna R.

Parkinsonism Relat Disord. 2021 Sep;90:125-133. doi: 10.1016/j.parkreldis.2021.09.005. Epub 2021 Sep 14.

Adrenal ganglioneuroma: Prognostic factors (Review)

Sandru F, Dumitrascu MC, Petca A, Carsote M, Petca RC, Oproiu AM, Ghemigian A.

Exp Ther Med. 2021 Nov;22(5):1338. doi: 10.3892/etm.2021.10773. Epub 2021 Sep 22.

Autoimmune mediated hyperkinetic movement disorders in SARS-CoV-2 infection - a systematic review

Hirschfeld AS.

Neurol Neurochir Pol. 2021;55(6):549-558. doi: 10.5603/PJNNS.a2021.0069. Epub 2021 Oct 12.

Opsoclonus-Myoclonus-Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?

Gizhlaryan M, Aghabekyan T, Arakelyan T, Petrosyan M, Iskanyan S, Tamamyan G, Sargsyan L, Papyan R.

Oncology (Williston Park). 2021 Oct 22;35(10):665-667. doi: 10.46883/ONC.2021.3510.0665.

DRPLA: An unusual disease or an underestimated cause of ataxia in Brazil?

Pinto WBVR, Salomão RPA, Bergamasco NC, da Cunha Ribas G, da Graça FF, Lopes-Cendes I, Bonadia L, de Souza PVS, Bulle Oliveira AS, Saraiva-Pereira ML, Jardim LB, Tumas V, Junior WM, França MC Jr, Pedroso JL, Barsottini OGP, Teive HAG.

Parkinsonism Relat Disord. 2021 Nov;92:67-71. doi: 10.1016/j.parkreldis.2021.10.004. Epub 2021 Oct 11.

[Neuronal ceroid lipofuscinosis. Type 6 late infantile variant in two compound heterozygous siblings with novel mutations]

Bravo-Oro A, Saavedra-Alanís VM, Reyes-Vaca JG, Espinosa-Tanguma R, Shiguetomi-Medina JM, Esmer C.

Rev Neurol. 2021 Nov 16;73(10):368-371. doi: 10.33588/rn.7310.2021174.

Creutzfeldt-Jakob disease: A case report

Salehian R, Sina F, Moudi S.

Caspian J Intern Med. 2021;12(Suppl 2):S359-S362. doi: 10.22088/cjim.12.0.359.

Breast cancer-associated opsoclonus-myoclonus syndrome: a case report

Kostoglou A, Vlastos D, Bakalis A, Ghosh D.

World J Surg Oncol. 2021 Nov 16;19(1):328. doi: 10.1186/s12957-021-02436-7.

Movement Disorders Associated with COVID-19

Salari M, Zaker Harofteh B, Etemadifar M, Sedaghat N, Nouri H.

Parkinsons Dis. 2021 Nov 8;2021:3227753. doi: 10.1155/2021/3227753. eCollection 2021.

Adult-onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS

Kim S, Kim MJ, Son H, Hwang S, Kang MK, Chu K, Lee SK, Moon J.

Ann Clin Transl Neurol. 2021 Dec;8(12):2319-2326. doi: 10.1002/acn3.51483. Epub 2021 Nov 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias